Curiox Biosystems
큐리옥스바이오시스템즈 · 445680
Health Care Medical Devices · KOSDAQ
Market cap US$1.2B (₩1.6T)
Overview
Curiox Biosystems makes automated equipment and consumables for cell analysis, the laboratory process of examining and measuring cells used in biological research, drug development, and diagnostics.
Its products are supplied to researchers and scientists working in those fields. The company's core technology washes cells using natural gravity rather than a centrifuge, which it says minimises cell damage and improves reproducibility; this capability is delivered largely through software that runs on widely used liquid-handling workstations from multiple established instrument brands. Curiox is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$4.9M
- FY2024US$3.3M
- FY2025US$3.7M
Operating profit
- FY2023−US$7.7M
- FY2024−US$9.7M
- FY2025−US$8.9M
Net income
- FY2023−US$7.3M
- FY2024−US$5.9M
- FY2025−US$19.7M
Key ratios (FY2025)
Why it matters
Its Pluto Code software is designed to run on liquid handlers from Hamilton, Tecan, Beckman Coulter, and Opentrons, making the platform hardware-agnostic across multiple established brands.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?